Načítá se...
In-vitro Activity of Avermectins against Mycobacterium ulcerans
Mycobacterium ulcerans causes Buruli ulcer (BU), a debilitating infection of subcutaneous tissue. There is a WHO-recommended antibiotic treatment requiring an 8-week course of streptomycin and rifampicin. This regime has revolutionized the treatment of BU but there are problems that include reliance...
Uloženo v:
| Vydáno v: | PLoS Negl Trop Dis |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Public Library of Science
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4351077/ https://ncbi.nlm.nih.gov/pubmed/25742173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0003549 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|